MARKETS / NYSE / CDRE

NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Cadre Holdings, Inc. CDRE

6 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$610.3M

▲ 7.5% YoY

Net income

$44.1M

▲ 22.2% YoY

Free cash flow

$56.8M

▲ 117.7% YoY

In brief

What this company does

Cadre Holdings sells body armor, explosive ordnance disposal equipment, duty gear, remote handling solutions, containers for the storage of radioactive materials, and ventilation and containment solutions through direct and indirect channels. It has a total of 2,533 employees, of whom 1,805 are engaged in manufacturing, 236 in sales, marketing, product management and customer support, 211 in corporate functions, 219 in research and development and engineering, 27 as retail store associates and 35 in executive and administrative functions. No individual customer accounts for more than 10% of its total revenue. The company operates a global manufacturing footprint with sites across North America and Europe. Its history in the safety equipment business dates back to 1964. Alpha Safety, a subsidiary founded in 1986, provides technical products and services spanning the nuclear value chain.

Written from the business description in CADRE HOLDINGS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 10 March 2026. Every sentence was checked against that document before publication.

Growth

USD 610.3M

Revenue, FY2025 · full 6-year series below

Revenue $M Net income $M

FY2025 · Revenue 610.3 · Net income 44.1

Compound annual growth

Revenue

+10.1%

+8.6%

Net income

+96.5%

+2.8%

EPS, diluted

+85.4%

−6.1%

Dividend / share

+5.9%

Returned to shareholders

+10.3%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at +8.6% a year over five years — but profit grew slower: net income at +2.8%, earnings per share at −6.1%.

The share count rose from 0.03B to 0.04B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

7 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 11.0% · Net 7.2%

ROE

FY2025 · ROE 14.0%

Gross margin42.5%

Operating margin11.0%

Net margin7.2%

Return on assets6.2%

EBITDAUSD 86.0M

Each USD of equity produced 14 cents of profit this year.

Cash & shareholders

USD 15.4M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF 56.8

Net buybacks $M Dividends $M

FY2025 · Dividends 15.4 · Net buybacks —

Dividends paidUSD 15.4M

Net buybacks—

Share of profit35.0%

Consecutive raises2 years

USD 15.4M in dividends — 35% of the year's profit went back to shareholders.

Total assetsUSD 770.0M

EquityUSD 317.8M

CashUSD 122.9M

Gross debtUSD 307.3M

Net debtUSD 184.4M

DepositsUSD 32.5M

Net debt stands at 58% of equity.

The 6-year record

6 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020
Revenue $B	0.6	0.6	0.5	0.5	0.4	0.4
Operating income $B	0.1	0.1	0.1	0.0	0.1	0.0
EBITDA $B	0.1	0.1	0.1	0.0	0.1	0.1
Income tax $B	0.0	0.0	0.0	0.0	0.0	−0.0
Net income $B	0.0	0.0	0.0	0.0	0.0	0.0
Free cash flow $B	0.1	0.0	0.1	0.0	0.0	0.0
EPS, diluted $	1.02	0.90	1.02	0.16	0.44	1.40
Dividend / sh $	0.10	0.09	0.08	0.08	·	·
Payout %	35	39	31	198	101	·
ROE %	14.0	14.2	21.3	4.6	26.0	434.4
Shares out B	0.04	0.04	0.04	0.04	0.03	0.03

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 6 of 19 fiscal years. 65 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

SEC categoryemerging growth company

Data on record since2020